Timely Reauthorization of PDUFA & MDUFA Is Critical to VC-backed Life Science Breakthroughs

by & filed under Medical Innovation, NVCA Blog.

Thirty years ago, the median time for the Food and Drug Administration (FDA) approval of a new drug was 33 months. As one can imagine, major backlog at the agency caused significant delay to the approval and entry of potentially life-saving drugs in the market. To address this problem, Congress passed the Prescription Drug User… Read more »